40.97
6.26 (18.02%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | MBX Biosciences, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 2.0 |
| 内部交易活动 | 1.5 |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 1.90 |
|
MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 3.12% |
| 机构持股比例 | 106.60% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Nvp Associates, Llc | 31 Dec 2025 | 2,136,335 |
| Aaron Wealth Advisors Llc | 31 Mar 2026 | 1,168,176 |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| HOERTER STEVEN L. | 29.78 | - | 11,938 | 355,514 |
| 累积净数量 | 11,938 | |||
| 累积净值 ($) | 355,514 | |||
| 累积平均购买 ($) | 29.78 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| HOERTER STEVEN L. | 董事 | 01 May 2026 | 获得 (+) | 11,938 | 29.78 | 355,514 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合